E
Entropy Neurodynamics Ltd
OTC:TYPTF
Entropy Neurodynamics Ltd
OTC:TYPTF
Price:
0.012
USD
Market Closed
Market Cap:
$13.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Entropy Neurodynamics Ltd
OTC:TYPTF
|
AU |
|
IPG Photonics Corp
NASDAQ:IPGP
|
US |
|
E
|
Easy Holdings Co Ltd
KOSDAQ:035810
|
KR |
|
Repay Holdings Corp
NASDAQ:RPAY
|
US |
|
Virbac SA
OTC:VRBCF
|
FR |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
Grupo Aeroportuario del Sureste SAB de CV
BMV:ASURB
|
MX |
|
Singapore Post Ltd
F:SGR
|
SG |
Intrinsic Value
Not Available for TYPTF
There is not enough data to reliably calculate the intrinsic value for Entropy Neurodynamics Ltd.
Do our valuations actually work? See backtest results .
Alternatives to TYPTF
Fundamental Analysis
What Entropy Neurodynamics Does
Tryptamine Therapeutics Ltd is a drug-development company focused on medicines built around tryptamine compounds, the chemical family that includes well-known psychedelic molecules. Its work is aimed at turning those compounds into controlled pharmaceutical treatments, especially for mental health and other medical uses where standard drugs may not be enough.
- Headquarters
- Australia AU
- IPO date
- Dec 18, 2018
Financials
Efficiency
Earnings Waterfall
Entropy Neurodynamics Ltd
Entropy Neurodynamics Ltd
